Company Profile

Takeda Pharmaceutical Co. Ltd. (NYSE: TAK)
5:00 PM UTC, 07/03/24
Last: $13.11 Change: +0.08 %Change: +0.61% Volume: 438,664
Detailed Quote
Open: $ 13.06   Volume: 438,664
High: $ 13.16   Yield(%) 4.31
Low: $ 13.06   P/E Ratio (ttm): 40.92
Dividend ($): 0.30   Market Cap ($): 40.89B
EPS ($) 0.32   Shares Out: 3.14B
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -2.76
% Price Change (last 13 weeks): -3.84
% Price Change (last 26 weeks): -9.14
% Price Change (last 52 weeks): -16.69
% Price Change (year to date): -8.69
Management Effectiveness
Return on Equity (%): 2.08
Return on Assets (%): 0.97
Return on Invested Capital (%): 2.15
Profitability
Gross Profit Margin (%): 54.53
Net Profit Margin (%): 3.38
Operating Profit Margin (%): 12.43
Price & Volume
50-day Moving Average: $13.17
200-day Moving Average: $14.09
Avg. Daily Vol. (last 50 days): 1,501,297
Avg. Daily Vol. (last 200 days): 1,767,884
52-wk high: $16.39
52-wk low: $12.57
Bid: $12.94
Ask: $13.50
Company Information
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Takeda Pharmaceutical Co. Ltd.
4-1-1 Dosho-machi Chuo-Ku
Osaka OS 540-8645

Phone: 81.6.6204.2111
Fax: 81.6.6204.2880
http://www.takeda.co.jp
Per Share Data
Earnings (1year) ($): 0.32
Annual Dividend ($): 0.56
Current P/E Ratio (ttm): 40.92
Book Value ($): 15.31
Cash Flow ($): 1.92
Valuation Ratios
Price/Earnings (x): 40.92
Price/Sales (x): 1.49
Price/Book (x): 0.91
Price/Cash Flow (x): 9.91
Financial Strength
Quick Ratio (x): 0.58
Current Ratio (x): 1.11
LT Debt/Equity (x): 69.16
Total Debt/Equity (x): 75.12



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.